Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system

Journal of Hypertension

Volumn 26, Issue 2, 2008, Pages 269-275

  Corry, Dalila B ^a   Eslami, Pirooz ^b,c   Yamamoto, Kei ^b,c   Nyby, Michael D ^b,c   Makino, Hirofumi ^b,c   Tuck, Michael L ^b,c  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Oxidative stress; Renin angiotensin system; Uric acid; Vascular smooth muscle cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 8 ISOPROSTANE; ANGIOTENSINOGEN; CAPTOPRIL; HYDROGEN PEROXIDE; LOSARTAN; NITRATE; NITRITE; THYMIDINE; URIC ACID;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; INCUBATION TIME; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 38148998838     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282f240bf     Document Type: Article

References (28)

1. Tykarski A. Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion. Nephron 1991; 59:364-368.
2. Selby JV, Friedman GD, Quesenberry CPJ. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990; 131:1017-1027.
3. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42:474-480.
4. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension 2003; 42:247-252.
5. Messerli FH, Frohlich ED, Dreslinski GR, Suarez DH, Aristimuno GG. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Arch Intern Med 1980; 93:817-821.
6. Puig JG, Ruilope LM. Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens 1999; 17:869-872.
7. Ramsay LE. Hyperuricemia in hypertension: role of alcohol. BMJ 1979; 1:653-654.
8. Sánchez-Fructuoso AI, Torralbo A, Arroyo M, Luque M, Ruilope LM, Santos JL, et al. Occult lead intoxication as a cause of hypertension and renal failure. Nephrol Dial Transplant 1996; 11:1775-1780.
9. Galvan AQ, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, Ferrannini E. Effect of insulin on uric acid excretion in humans. Am J Physiol 1995; 268:E1-E5.
10. Tsunoda S, Kamide K, Minami J, Kawano Y. Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent. Am J Hypertens 2002; 15:697-701.
11. Masuo K, Katsuya T, Fu Y, Rakugi H, Ogihara T, Tuck M. Lys418Asn polymorphism of the α2-adrenoceptor gene relates to serum uric acid levels but not to insulin sensitivity. Hypertension 2005; 46:144-150.
12. Saito I, Saruta T, Kondo K, Nakamura R,Oguro T, Yamagami K, et al. Serum uric acid and the renin-angiotensin system in hypertension. J Am Geriatr Soc 1978; 26:241-247.
13. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet derived growth factor A-chain expression. J Biol Chem 1991; 266:8604-8608.
14. Berk BC, Rao GN. Angiotensin II-induced vascular smooth muscle cell hypertrophy: PDGF A-chain mediates the increase in cell size. J Cell Physiol 1993; 154:368-380.
15. Berk BC. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev 2001; 81:999-1030.
16. Kamide K, Hori MT, Zhu J, Barrett J, Eggena P, Tuck ML. Insulin-mediated growth in aortic smooth muscle and vascular renin-angiotensin system. Hypertension 1998; 32:482-487.
17. Tuck ML, Bounoua F, Eslami P, Nyby MD, Eggena P, Corry DB. Insulin stimulates endogenous angiotensin II production via a mitogen-activated protein kinase pathway in vascular smooth muscle cells. J Hypertens 2004; 22:1779-1785.
18. Han L, Kanellis J, Li P, Feng L, Nakagawa T, Kooyer S, et al. The evidence for a functional organic anion transporter in vascular smooth muscle cells. Presented at American Society of Nephrology 35th Annual Meeting and Scientific Exposition. Philadelphia, PA; 30 October-4 November 2002. Abstract 13:329A.
19. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, et al. Hyperuricemia induces a primary arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002; 282:F991-F997.
20. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003; 41:1287-1293.
21. Perlstein TS, Gumieniak O, Hopkins PN, Murphey LF, Brown NJ, Williams GH, et al. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int 2004; 66:1465-1470.
22. Houston M, Chumley P, Radi R, Rubbo H, Freeman BA. Xanthine oxidase reaction with nitric oxide and peroxynitrite. Arch Biochem Biophys 1998; 355:1-8.
23. Bagnati M, Perugini C, Cau C, Bordone R, Albano E, Bellomo G. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem J 1999; 340:143-152.
24. Schlotte V, Sevanian A, Hochstein P, Weithmann KU. Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro. Free Rad Biol Med 1998; 25:839-847.
25. Zhang H, Schmeisser A, Garlichs CD, Plotze K, Damme U, Mugge A, Daniel WG. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res 1999; 44:215-222.
26. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJ, Dominiczak AF. Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 2000; 101:2206-2212.
27. Kawazoe T, Kosaka H, Yoneyama H, Hata Y. Acute production of vascular superoxide by angiotensin II but not by catecholamines. J Hypertens 2000; 18:179-185.
28. Hoieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, de Faire U, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2003; 65:1041.